(Q35569894)

8 August 2017

title

Substitution management in opioid dependence (English)

1 reference

8 August 2017

A. Uchtenhagen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582802

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582802

26 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

http://link.springer.com/content/pdf/10.1007/978-3-7091-0541-2_3.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Journal of neural transmission. Supplementum

26 March 2024

published in

1 reference

8 August 2017

issue

66

1 reference

8 August 2017

page(s)

33-60

1 reference

Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet

8 August 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

The heroin prescribing debate: integrating science and politics.

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Contingency management of urinalysis results and intensity of counseling services have an interactive impact on methadone maintenance treatment outcome

26 March 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

A comparison of abstinence-oriented and indefinite methadone maintenance treatment

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Survey assessment of methadone treatment services as reinforcers

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Mapping-enhanced drug abuse counseling: Urinalysis results in the first year of methadone treatment

26 March 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

26 March 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Evaluation of heroin maintenance in controlled trial

26 March 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

A cooperative clinical study of methadyl acetate. II. Friday-only regimen

26 March 2024

29

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

The effects of psychosocial services in substance abuse treatment.

26 March 2024

30

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Rapid Admission and Retention on Methadone

26 March 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

26 March 2024

33

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.

26 March 2024

34

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency

26 March 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand

26 March 2024

42

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Methadone/LAAM maintenance: a comparison study

26 March 2024

44

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

A confidential enquiry into methadone-related deaths

26 March 2024

45

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Medical maintenance: an interim report

26 March 2024

48

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Contingent take-home incentive: effects on drug use of methadone maintenance patients

26 March 2024

52

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Heroin Prescribing in the British System: Historical Review

26 March 2024

53

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women

26 March 2024

54

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).

26 March 2024

55

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Clinical pharmacology of buprenorphine: ceiling effects at high doses

26 March 2024

60

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

Psychotherapy in community methadone programs: a validation study

26 March 2024

63

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-0541-2_3

26 March 2024

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582802

26 March 2024

1 reference